18F-FDG PET successfully detects spinal cord sarcoidosis

Journal of Neurology

Volumn 256, Issue 11, 2009, Pages 1943-1946

  Ota, Kiyobumi ^a   Tsunemi, Taiji ^b   TsunemiSaito, Kazuyoshi ^a   Yamanami, Fumika ^a   Watanabe, Mutsufusa ^a   Irioka, Takashi ^a   Mizusawa, Hidehiro ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

18F FDG PET; Cervical spondylosis; Gallium scintigraphy; Neurosarcoidosis; Sarcoidosis

Indexed keywords

DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

AGED; CASE REPORT; HUMAN; LETTER; MALE; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; SARCOIDOSIS; SCINTISCANNING; SPINAL CORD DISEASE;

AGED; AGED, 80 AND OVER; FLUORODEOXYGLUCOSE F18; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SARCOIDOSIS; SPINAL CORD DISEASES;

EID: 73449110242     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-009-5270-8     Document Type: Article

References (15)

1. Hoitsma E, Faber CG, Drent M, Sharma OP (2004) Neurosarcoidosis: A clinical dilemma. Lancet Neurol 3:397-407 (Pubitemid 38789135)
2. Zajicek JP, Scolding NJ, Foster O, Rovaris M, Evanson J, Moseley IF, Scadding JW, Thompson EJ, Chamoun V, Miller DH, McDonald WI, Mitchell D (1999) Central nervous system sarcoidosis-diagnosis and management. QJM 92:103-117 (Pubitemid 29097635)
3. Saleh S, Saw C, Marzouk K, Sharma O (2006) Sarcoidosis of the spinal cord: Literature review and report of eight cases. J Natl Med Assoc 98:965-976
4. Sulavik SB, Spencer RP, Weed DA, Shapiro HR, Shiue ST, Castriotta RJ (1990) Recognition of distinctive patterns of gallium-67 distribution in sarcoidosis. J Nucl Med 31:1909-1914
5. Larson SM, Milder MS, Johnston GS (1972) Interpretation of the 67 Ga photoscan. J Nucl Med 14:208-214
6. Pickuth D, Heywang-Köbrunner SH (2000) Neurosarcoidosis: Evaluation with MRI. J Neuroradiol 27:185-188
7. Rohren EM, Turkington TG, Coleman RE (2004) Clinical applications of PET in oncology. Radiology 231:305-332 (Pubitemid 38552885)
8. Omuro AM, Leite CC, Mokhtari K, Delattre JY (2006) Pitfalls in the diagnosis of brain tumours. Lancet Neurol 5:937-948 (Pubitemid 44574407)
9. Nishiyama Y, Yamamoto Y, Fukunaga K, Takinami H, Iwado Y, Satoh K, Ohkawa M (2006) Comparative evaluation of 18F-FDG PET and 67 Ga scintigraphy in patients with sarcoidosis. J Nucl Med 47:1571-1576 (Pubitemid 47545019)
10. Xiu Y, Yu JQ, Cheng E, Kumar R, Alavi A, Zhuang H (2005) Sarcoidosis demonstrated by FDG PET imaging with negative findings on gallium scintigraphy. Clin Nucl Med 30:193-195 (Pubitemid 40270972)
11. Aide N, Benayoun M, Kerrou K, Khalil A, Cadranel J, Talbot JN (2007) Impact of [18F]-fluorodeoxyglucose([18F]-FDG) imaging in sarcoidosis: Unsuspected neurosarcoidosis discovered by [18F]-FDG PET and early metabolic response to corticosteroid therapy. Br J Radiol 80:e67-e71
12. Dubey N, Miletich RS, Wasay M, Mechtler LL, Bakshi R (2002) Role of fluorodeoxyglucose positron emission tomography in the diagnosis of neurosarcoidosis. J Neurol Sci 205:77-81 (Pubitemid 36158997)
13. Spencer TS, Campellone JV, Maldonado I, Huang N, Usmani Q, Reginato AJ (2005) Clinical and magnetic resonance imaging manifestations of neurosarcoidosis. Semin Arthritis Rheum 34:649-661 (Pubitemid 40193363)
14. Baron EM, Young WF (2007) Cervical spondylotic myelopathy: A brief review of its pathophysiology, clinical course, and diagnosis. Neurosurgery 60:35-41
15. Cohen PR, Kurzrock R (2007) Sarcoidosis and malignancy. Clin Dermatol 25:326-333 (Pubitemid 46863481)